APA (7th ed.) Citation

LL, J., TT, H., LL, M., YF, X., WY, C., WW, W., & LH, W. (2023). The gut microbiota metabolite butyrate mitigates MPTP/MPP+ -induced Parkinson's disease by inhibiting the JAK2/STAT3 signaling pathway. The Kaohsiung journal of medical sciences, 39(10), 1002. https://doi.org/10.1002/kjm2.12745

Chicago Style (17th ed.) Citation

LL, Ji, Huang TT, Mao LL, Xu YF, Chen WY, Wang WW, and Wang LH. "The Gut Microbiota Metabolite Butyrate Mitigates MPTP/MPP+ -induced Parkinson's Disease by Inhibiting the JAK2/STAT3 Signaling Pathway." The Kaohsiung Journal of Medical Sciences 39, no. 10 (2023): 1002. https://doi.org/10.1002/kjm2.12745.

MLA (9th ed.) Citation

LL, Ji, et al. "The Gut Microbiota Metabolite Butyrate Mitigates MPTP/MPP+ -induced Parkinson's Disease by Inhibiting the JAK2/STAT3 Signaling Pathway." The Kaohsiung Journal of Medical Sciences, vol. 39, no. 10, 2023, p. 1002, https://doi.org/10.1002/kjm2.12745.